116 related articles for article (PubMed ID: 22781764)
21. Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 study.
D'Armini AM; Ghofrani HA; Kim NH; Mayer E; Morsolini M; Pulido-Zamudio T; Simonneau G; Wilkins MR; Curram J; Davie N; Hoeper MM
J Heart Lung Transplant; 2015 Mar; 34(3):348-55. PubMed ID: 25813765
[TBL] [Abstract][Full Text] [Related]
22. Diagnostics in pulmonary hypertension.
Schannwell CM; Steiner S; Strauer BE
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):591-602. PubMed ID: 18204173
[TBL] [Abstract][Full Text] [Related]
23. [Investigation and analysis for current situation and pathogenesis relevant to pulmonary hypertension].
Lei S; Tang D; Xu N; Wu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):641-646. PubMed ID: 28690220
[TBL] [Abstract][Full Text] [Related]
24. [Two years of multidisciplinary diagnostic and therapeutic experience in patients with pulmonary arterial hypertension].
Tokgözoğlu L; Akdoğan A; Okutucu S; Kaya EB; Aytemir K; Ozkutlu H
Turk Kardiyol Dern Ars; 2009 Sep; 37(6):378-83. PubMed ID: 20019450
[TBL] [Abstract][Full Text] [Related]
25. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension.
Zlupko M; Harhay MO; Gallop R; Shin J; Archer-Chicko C; Patel R; Palevsky HI; Taichman DB
Respir Med; 2008 Oct; 102(10):1431-8. PubMed ID: 18617379
[TBL] [Abstract][Full Text] [Related]
27. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
28. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A
G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005
[TBL] [Abstract][Full Text] [Related]
29. [Female gender and pulmonary arterial hypertension: a complex relationship].
Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
[TBL] [Abstract][Full Text] [Related]
30. [Clinical-hemodynamic correlation of the NYHA/WHO system in idiopathic pulmonary artery hypertension. Clinical, therapeutic and long-term prognosis implications].
Herrera EL; Zárate JS; Solano JF; Martínez LE; Zamudio TR; Bautista EG
Arch Cardiol Mex; 2008; 78(2):148-61. PubMed ID: 18754406
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.
Andersen KH; Iversen M; Kjaergaard J; Mortensen J; Nielsen-Kudsk JE; Bendstrup E; Videbaek R; Carlsen J
J Heart Lung Transplant; 2012 Apr; 31(4):373-80. PubMed ID: 22226804
[TBL] [Abstract][Full Text] [Related]
32. A hemodynamic study of pulmonary hypertension in sickle cell disease.
Parent F; Bachir D; Inamo J; Lionnet F; Driss F; Loko G; Habibi A; Bennani S; Savale L; Adnot S; Maitre B; Yaïci A; Hajji L; O'Callaghan DS; Clerson P; Girot R; Galacteros F; Simonneau G
N Engl J Med; 2011 Jul; 365(1):44-53. PubMed ID: 21732836
[TBL] [Abstract][Full Text] [Related]
33. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension.
Reesink HJ; Tulevski II; Marcus JT; Boomsma F; Kloek JJ; Vonk Noordegraaf A; Bresser P
Ann Thorac Surg; 2007 Aug; 84(2):537-43. PubMed ID: 17643631
[TBL] [Abstract][Full Text] [Related]
34. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study.
Vizza CD; Badagliacca R; Sciomer S; Poscia R; Battagliese A; Schina M; Agati L; Fedele F
Cardiology; 2006; 106(3):168-73. PubMed ID: 16645271
[TBL] [Abstract][Full Text] [Related]
35. Unexplained severe pulmonary hypertension in the elderly: report on 14 patients.
Yigla M; Kramer MR; Bendayan D; Reisner SA; Solomonov A
Isr Med Assoc J; 2004 Feb; 6(2):78-81. PubMed ID: 14986462
[TBL] [Abstract][Full Text] [Related]
36. [Clinical efficacy of intravenous L-carnitine in patients with right-sided heart failure induced by pulmonary arterial hypertension].
Xu XQ; Jing ZC; Jiang X; Zhao QH; He J; Dai LZ; Wu WH; Li Y; Yao J
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):152-5. PubMed ID: 20398563
[TBL] [Abstract][Full Text] [Related]
37. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
Marinato PG; Dametto E; Maragno I; Razzolini R; Chinellato P; Santostasi G; Dalla Volta S
Cardiologia; 1996 Apr; 41(4):349-59. PubMed ID: 8674104
[TBL] [Abstract][Full Text] [Related]
38. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
Luo L; Yang YH; Cui N; Xie WM; Zhai ZG; Ma ZH; Wang C
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2103-5. PubMed ID: 20058612
[TBL] [Abstract][Full Text] [Related]
39. Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension.
Zhang DZ; Zhu XY; Meng J; Xue HM; Sheng XT; Han XM; Cui CS; Wang QG; Zhang P
Int J Cardiol; 2011 Mar; 147(3):433-7. PubMed ID: 20537740
[TBL] [Abstract][Full Text] [Related]
40. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center].
Kayikçioğlu M; Kültürsay H
Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
